AMXI-3001

N/A

Report date: 2023/05/22 10:17:13
NME

Base Information

Drug NameAMXI-3001
Drug Alias NameAMXI-3001
ClassificationSmall molecules
Mechanisms of ActionPoly (ADP-Ribose) polymerase inhibitorsBcr-Abl tyrosine kinase inhibitors
TargetsBcr-Abl tyrosine kinasePoly (ADP-Ribose) polymerase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAtlasMedx Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesAtlasMedx Incorporated
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A